ANGO
AngioDynamicsBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
If restructuring and acquisition synergies materialize as outlined in the 2025 10-K and procedure volumes recover, AngioDynamics can re-rate toward the analyst high as margins expand and cash conversion improves.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +6.8.
What can break
Integration costs from acquisitions exceeding projections
Momentum
67
Value
41
Sentiment
75
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $17.50 · Bull $24.00 · Bear $8.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-03 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $19.33
Why
Momentum67 · Δ7d -5.6
Value41 · Δ7d -0.0
Sentiment75 · Δ7d +6.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Sentiment · See AI snapshot
Momentum
67
34% active weight
Current posture
7d trendImproving
Δ7d
-5.6
Δ21d
+1.8
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
75
33% active weight
Current posture
7d trendImproving
Δ7d
+6.8
Δ21d
0.0
Why this grade
Composite grade B. Momentum 66.6 / Value 41.3 / Sentiment 74.7
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$450.79M
Beta
0.52
Shares Out
41.2M
P/E (TTM) · Derived
-182.4
P/S (TTM)
1.81
P/FCF (TTM) · Derived
-37.70
Rev YoY
+12.2%
EPS YoY
+15.9%
Gross Margin
+54.1%
Op Margin
-12.5%
Net Debt
-$49.69M
Current Ratio
2.29
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology